Exciting Pipeline and Market Potential in Animal Health

In this chapter, the hosts delve into Elanco Animal Health's innovative product pipeline for pets and livestock, highlighting potential blockbusters and unmet needs in the industry. They discuss recently approved and launched products, including a monoclonal antibody for puppies and a tablet for cats with diabetes, while also touching upon Elanco's initiatives in the farm animal sector and their strategies to reduce debt. The importance of innovation, value, and the impact of COVID on the humanization of pets are also discussed, showcasing the durability and resilience of the animal health market.